A small-cap biotech just announced novel data and the filing of a patent application describing a unique mechanism of action of its JadiCell™ universal donor stem cell, according to the release. Shares of Therapeutic Solutions International Inc. (OTCPK:TSOI) rallied on the news.
Therapeutic Solutions focuses on immune modulation for the treatment of several specific diseases. It is engaged in developing a range of immune-modulatory agents to target certain cancers, improve maternal and fetal health, fight periodontal disease, and for daily health. The business divisions of the company are Nutraceutical Division, which produces ProJuvenol, a synergistic blend of complex anti-aging ingredients to help promote cellular rejuvenation and healthy functionality, Emvolio, Inc. which develops products that can be used together to attack cancer as different levels, and sandbox dental labs, Inc. consists of dental laboratory to manufacture and fill prescriptions from dentist.
Traders were bullish on the news as shares quickly climbed up to $0.077/share (+10%) following the announcement. This move is a strong continuation of the success this stock has had since the start of this month as it continues its surge back toward the 52-week high of $0.1729/share